Ironwood Pharmaceuticals
IRWD
IRWD
158 hedge funds and large institutions have $2.29B invested in Ironwood Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 51 increasing their positions, 49 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
4.16% less ownership
Funds ownership: 138.95% → 134.79% (-4.2%)
8% less capital invested
Capital invested by funds: $2.48B → $2.29B (-$188M)
Holders
158
Holding in Top 10
3
Calls
$17.8M
Puts
$8.92M
Top Buyers
| 1 | +$24.7M | |
| 2 | +$14.1M | |
| 3 | +$13.5M | |
| 4 |
PWAM
Park West Asset Management
San Francisco,
California
|
+$9.2M |
| 5 |
JP Morgan Chase
New York
|
+$6.4M |
Top Sellers
| 1 | -$44.5M | |
| 2 | -$40.2M | |
| 3 | -$20.9M | |
| 4 |
O
OrbiMed
New York
|
-$18.5M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$15.2M |